Dr. Öğr. Üyesi FATİH YULAK

Yayın Ağı

Makaleler 22

1. HER-2 SMASH

Alandağ C., ÖZTÜRK A., YULAK F., ŞAHİN İNAN Z. D., Karaca M., LAÇİN B. B., et al.

Cancer Chemotherapy and Pharmacology , cilt.95, sa.1, 2025 (SCI-Expanded)

2. Investigation of the antitumor activity of lapatinib and NNC 55-0396 dihydrochloride combination in gastric adenocarcinoma

Gömeç M., YULAK F., ERGÜL M.

Medical Oncology , cilt.42, sa.9, 2025 (SCI-Expanded)

3. Esomeprazole Potentiates the Cytotoxic Effects of Cisplatin in Gastric Carcinoma Cells

JOHA Z., Kalkan O., YULAK F., ERGÜL M., GEDİKLİ M. A.

Journal of Biochemical and Molecular Toxicology , cilt.39, sa.8, 2025 (SCI-Expanded)

4. Enoxaparin Protects C6 Glioma Cells from Glutamate-Induced Cytotoxicity by Reducing Oxidative Stress and Apoptosis

YULAK F., JOHA Z., ÖZTÜRK A., ŞAHİN İNAN Z. D., TAŞKIRAN A. Ş.

Molecular Neurobiology , cilt.62, sa.4, ss.4631-4640, 2025 (SCI-Expanded, Scopus)

5. Effect of pH on the synthesis of silica nanoparticles, their characterisation and investigation of their cytotoxic activities on the L929 cell line

KÜTÜK N., YULAK F., GÜNEŞ H.

Indian Chemical Engineer , 2025 (ESCI)

6. Tannic acid protects neuroblastoma cells against hydrogen peroxide – triggered oxidative stress by suppressing oxidative stress and apoptosis

YULAK F., ERGÜL M.

Brain Research , cilt.1844, 2024 (SCI-Expanded)

7. A PLK1 inhibitor, RO3280, suppresses proliferation of SNU-16 gastric cancer cells via apoptosis

YULAK F., Keskin Z.

Bangladesh Journal of Pharmacology , cilt.19, sa.2, ss.43-51, 2024 (SCI-Expanded)

8. Unveiling the Protective Potential of Sugammadex against PTZ-Induced Epileptic Seizures in Mice: A Comprehensive Study on Oxidative Stress, Apoptosis, and Autophagy.

Karademir M., Öztürk A., Yulak F., Özkaraca M., Taşkıran A. Ş.

Neurochemical Journal , cilt.18, ss.338-347, 2024 (Hakemli Dergi)

9. Lycopene induces antiproliferative effects through apoptosis, autophagy, and oxidative DNA damage in the HeLa cells

PARLAK M., JOHA Z., YULAK F., Mendil A. S., TAŞTEMUR Y.

Journal of Receptors and Signal Transduction , cilt.44, sa.3, ss.115-121, 2024 (SCI-Expanded)

10. Evaluation of the Antitumor Activity of Omipalisib, a PI3K/AKT/MTOR Pathway Inhibitor, on Burkitt Lymphoma Cell Line

KESKİN Z., YULAK F., TERZİ H., İNANIR M.

Cumhuriyet Science Journal , cilt.44, sa.4, ss.635-639, 2023 (Hakemli Dergi)

11. Mechanism of anticancer effect of ETP-45658, a PI3K/AKT/mTOR pathway inhibitor on HT-29 Cells

YULAK F., FİLİZ A. K., JOHA Z., ERGÜL M.

Medical Oncology , cilt.40, sa.12, 2023 (SCI-Expanded)

12. FGF-18 alleviates memory impairments and neuropathological changes in a rat model of Alzheimer's disease

Ciltas A., Karabulut S., Sahin B., Filiz A. K., Yulak F., Ozkaraca M., et al.

Neuropeptides , cilt.101, 2023 (SCI-Expanded)

13. Mechanism of anticancer effect of gambogic acid on gastric signet ring cell carcinoma

Joha Z., Öztürk A., Yulak F., Karataş Ö., Ataseven H.

Medical Oncology , cilt.40, sa.9, 2023 (SCI-Expanded)

14. GSK461364A suppresses proliferation of gastric cancer cells and induces apoptosis

Ataseven D., Taştemur Ş., YULAK F., KARABULUT S., ERGÜL M.

Toxicology in Vitro , cilt.90, 2023 (SCI-Expanded)

15. Anticancer activity of sinapic acid by inducing apoptosis in HT-29 human colon cancer cell line

Taştemur Ş., Hacisüleyman L., KARATAŞ Ö., YULAK F., ATASEVEN H.

Canadian Journal of Physiology and Pharmacology , cilt.101, sa.7, ss.361-368, 2023 (SCI-Expanded, Scopus)

16. Investigation of The Antiproliferative Effect of Colchicine on SNU-1 Gastric Cancer Cells

yulak f.

Cumhuriyet Science Journal , cilt.44, sa.2, ss.263-267, 2023 (Hakemli Dergi)

17. Levetiracetam Protects Against Glutamate-Induced Excitotoxicity in SH-SY5Y Cell Line

ÇETİNDAĞ ÇİLTAŞ A., Gündoğdu S., YULAK F.

International Journal of Nature and Life Sciences , cilt.6, sa.2, ss.142-150, 2022 (Hakemli Dergi)

18. Death receptor-dependent apoptosis and cell cycle delay induced by bioymifi in human cervical cancer cells

ALTUN A., ŞAHİN İNAN Z. D., YULAK F.

PAKISTAN JOURNAL OF PHARMACEUTICAL SCIENCES , cilt.35, sa.4, ss.1031-1036, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

19. Investigation of the potential antitumor activity of PLK1 inhibitor SBE13 in colon cancer cell line HT29

GÖMEÇ M., YULAK F., ERGÜL M.

Cumhuriyet Tıp Dergisi (ELEKTRONİK) , cilt.44, sa.2, ss.218-222, 2022 (Hakemli Dergi) Sürdürülebilir Kalkınma

20. Synthesis of diaryl urea derivatives and evaluation of their antiproliferative activities in colon adenocarcinoma

GÖMEÇ M., YULAK F., GEZEGEN H., ÖZKARACA M., SAYIN K., ATASEVEN H.

JOURNAL OF MOLECULAR STRUCTURE , cilt.1254, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

21. The Anticancer Effect of Cannabinoid 2 Agonist L-759,633 on C6 and SH-SY5Y Cell Lines

Joha Z., Yulak F., Öztürk A., Şahin B., Yıldırım Ş.

Turkish Journal of Science and Health , cilt.2, sa.3, ss.6-13, 2021 (Hakemli Dergi) Sürdürülebilir Kalkınma

22. Mechanism of anti-cancer effect of beta-glucan on SH-SY5Y cell line

FİLİZ A. K., Joha Z., YULAK F.

BANGLADESH JOURNAL OF PHARMACOLOGY , cilt.16, sa.4, ss.122-128, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 2

1. GSK461364A, A SPECIFIC INHIBITOR OF POLO-LIKE KINASE 1, SUPPRESSES PROLIFERATION OF SNU-1 CELLS THROUGH MEDIATING APOPTOSIS

Ataseven D., Taştemur Ş., YULAK F., ERGÜL M.

II. International Cancer Days, 16 Eylül 2021, (Özet Bildiri)

2. INVESTIGATION OF THE EFFECT OF CISPLATIN ON FETUIN A IN THE SH-SY5Y CELL LINE

JOHA Z., YULAK F., FİLİZ A. K.

INTERNATIONAL GEVHER NESIBE HEALTH SCIENCES CONFERENCE-VII, Kayseri, Türkiye, 16 Nisan 2021, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scholar)

145

H-İndeks (Scholar)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler